ENSOCELL LTD
Research and experimental development on biotechnology
ENSOCELL LTD
Research and experimental development on biotechnology
Previous Company Names
Contact & Details
Contact
Registered Address
The Eddeva Building, B920 Babraham Research Campus Cambridge CB22 3AT England
Full company profile for ENSOCELL LTD (14714531), an active life sciences and medical technology company based in Cambridge, England. Incorporated 8 Mar 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2023–2024)
Cash in Bank
£6.58M
Net Assets
£8.24M
Total Liabilities
£66.32k
Turnover
N/A
Employees
7
Debt Ratio
1%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 Dec Year End | 2024 Dec Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (2)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 1 | Feb 2025 | Seed |
| Investor 2 | Feb 2025 | Seed |
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| John Shields | Director | British | England | 7 Dec 2023 | Active |
| Kiener, Peter, Dr | Director | English,american | United States | 30 Oct 2025 | Active |
See all 12 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (0)
Alexander Robert Leech
Ceased 18 Jul 2023
Group Structure
Group Structure
No group structure identified
Charges
Charges
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 29 Apr 2026 | Officers | Termination of Alexander Robert Leech as director on 29 Apr 2026 | |
| 29 Apr 2026 | Officers | Appointment of Dr Linda Grace Slanec Higgins as director on 9 Feb 2026 | |
| 19 Mar 2026 | Confirmation Statement | Confirmation statement made on 7 Mar 2026 with updates | |
| 6 Mar 2026 | Capital | Capital Name Of Class Of Shares | |
| 13 Feb 2026 | Incorporation | Memorandum Articles |
Termination of Alexander Robert Leech as director on 29 Apr 2026
Appointment of Dr Linda Grace Slanec Higgins as director on 9 Feb 2026
Confirmation statement made on 7 Mar 2026 with updates
Capital Name Of Class Of Shares
Memorandum Articles
Recent Activity
Latest Activity
Termination of Alexander Robert Leech as director on 29 Apr 2026
2 weeks ago on 29 Apr 2026
Appointment of Dr Linda Grace Slanec Higgins as director on 9 Feb 2026
2 weeks ago on 29 Apr 2026
Confirmation statement made on 7 Mar 2026 with updates
1 months ago on 19 Mar 2026
Capital Name Of Class Of Shares
2 months ago on 6 Mar 2026
Memorandum Articles
2 months ago on 13 Feb 2026